Monocytic Expression of HLA-DR After Liver Transplantation

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

July 14, 2023

Study Completion Date

July 14, 2023

Conditions
Liver DiseasesLiver TransplantationCirrhosis, Liver
Interventions
BIOLOGICAL

blood sample

"Samples will be collected at the inclusion and repeated if necessary before LT, including one 4 mL EDTA sample and one 4 mL Heparin sample and one 2.5 mL PAXgene® sample, allowing the HLA-DR assay to be performed with also plasma aliquots and messenger RNAs.~Same samples will also be collected :~* between inclusion and LT in case of major clinical change~* During the pre-transplant follow-up 3 months after inclusion, for patients who have not been transplanted within 3 months after inclusion~* at day 1 after LT~* 2 times a week after the LT for a maximum of 1 month~Biological data will be collected at those different times."

Trial Locations (3)

69003

Service d'hépato gastroentérologie hôpital Edouard Herriot Groupement hospitalier centre, Lyon

69004

Hopital de la Croix-Rouse, service de réanimation chirurgicale, Lyon

Hospital de la Croix Rousse, service d'hépatologie, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03995537 - Monocytic Expression of HLA-DR After Liver Transplantation | Biotech Hunter | Biotech Hunter